EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access

Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers

Ayo S Falade, Mary C Boulanger, Kelly Hsu, Roshni Sarathy, Riley Fadden, Kerry L Reynolds, Lara Traeger, Jennifer S Temel, Joseph A Greer, Laura A Petrillo

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08868-7 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Ayo S Falade und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Melanoma, Lung Neoplasms, Caregivers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Conquer Cancer Foundation, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsMelanomaLung NeoplasmsCaregiversQualitative ResearchHumansMaleFemaleAgedMiddle AgedCarcinoma, Non-Small-Cell LungAdultAged, 80 and overInterviews as Topic

Stichwörter der Autor:innen

Caregivers' perspectivesCommunicationHumanistic medicineImmune-related adverse eventsPatients' perspectives

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
  • Department of Medicine, Massachusetts General Brigham Salem Hospital, Salem, MA, USA.
  • Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Zucker School of Medicine, Hempstead, NY, USA.
  • Division of Palliative Care and Geriatrics, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

Förderung

  • NCI NIH HHS
  • Conquer Cancer Foundation
  • American Cancer Society
  • Division of Cancer Prevention, National Cancer Institute

Zitieren

APA

Falade, A. S., Boulanger, M. C., Hsu, K., Sarathy, R., Fadden, R., Reynolds, K. L., Traeger, L., Temel, J. S., Greer, J. A., & Petrillo, L. A. (2024). Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08868-7

Vancouver

Falade AS, Boulanger MC, Hsu K, Sarathy R, Fadden R, Reynolds KL, et al. Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08868-7

BibTeX
@article{Falade2024,
  author = {Falade, Ayo S and Boulanger, Mary C and Hsu, Kelly and Sarathy, Roshni and Fadden, Riley and Reynolds, Kerry L and Traeger, Lara and Temel, Jennifer S and Greer, Joseph A and Petrillo, Laura A},
  title = {Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08868-7}
}
Kostenlos starten →